ArticleRheumatology advances in practice2025

Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls.

Ingrid Egeland Christensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.